Drug discovery chemists are often plagued with two very common issues: what is the most efficient way to test their hypothesis and how can they iterate on those ideas quickly. A shift from design strategies based on trial and error towards a ‘predict-first’ approach to drug discovery allows teams to drastically expand the pool of molecules that can be explored and results in a highly interactive and fully in silico design-make-test-analyze (DMTA) cycle. Schrödinger looked to C&EN Media Group to develop a strategy on how they could effectively showcase the digital chemistry strategy used by their clinical-stage drug candidates and demonstrate how this strategy based in LiveDesign, Schrödinger’s cloud-native, collaborative enterprise informatics platform, empowers teams to design, computationally assess, and prioritize new compounds together in real-time.

With a strong promotional strategy developed, the C&EN Media Group team launched a campaign to promote Schrödinger’s webinar titled The Predict-First Paradigm: How Digital Chemistry is Changing Drug Discovery.

Wade Miller, Olivia Lynes, and Eugene Hickey and Alice Hooper – Senior Research Leaders and Senior Scientists from Schrödinger’s Therapeutics Group – demonstrated how teams can confidently spend time and energy exploring new, unknown, and often more complex designs while sending only the top performing molecules for synthesis. The speakers illustrated how a predict-first strategy can accelerate and improve the drug discovery process, how centralized technology used by Schrödinger scientists enhances crowdsourced ideation and team collaboration, and how to overcome collaboration hurdles to increase project efficiency.

This webinar campaign proved to be highly effective, resulting in increased conversions among scientists eager to make advances in the drug discovery field. Thanks to this strategy, C&EN Media Group surpassed the guaranteed lead goal of 400 by over 200%. The following results illustrate how C&EN Media Group successfully created and delivered an impressive pipeline of potential customers for Schrödinger.